Skip to main content
. 2017 Jul 11;24:43. doi: 10.1186/s12929-017-0349-5

Fig. 1.

Fig. 1

a The erythropoietin resistance index (ERI) levels in both erythropoietin (EPO) resistant and responsive groups (p = 0.017). b Correlation between end-stage renal disease patients’ clinical features and erythropoietin (EPO) responsiveness. Significant correlations between clinical features and EPO responsive status are denoted by “*”. Y-axis, mean square contingency coefficient